{"ORPHApacket":[{"ORPHApacketID":"35069","date":"2019-12-05 17:31:59","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"35069","Name":[{"lang":"en","label":"Infantile neuroaxonal dystrophy"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_35069","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Genetic peripheral neuropathy"}],"ORPHA":"98497","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_98497"},{"Name":[{"lang":"en","label":"PLA2G6-associated neurodegeneration"}],"ORPHA":"329303","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_329303"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"Infantile neuroaxonal dystrophy\/atypical neuroaxonal dystrophy (INAD\/atypical NAD) is a type of neurodegeneration with brain iron accumulation (NBIA; see this term) characterized by psychomotor delay and regression, increasing neurological involvement with symmetrical pyramidal tract signs and spastic tetraplegia. INAD may be classic or atypical and patients present with symptoms anywhere along a continuum between the two."}],"ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"OMIM","Reference":"256600","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]},{"Source":"OMIM","Reference":"610217","DisorderMappingRelation":[{"id":"21541","Name":[{"lang":"en","label":"BTNT (broader term maps to a narrower term)"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"2","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Infancy"}]},{"Name":[{"lang":"en","label":"Neonatal"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal recessive"}]}]}],"SynonymList":[{"count":"5","Synonym":[{"lang":"en","label":"INAD"},{"lang":"en","label":"INAD1"},{"lang":"en","label":"PLAN"},{"lang":"en","label":"Phospholipase A2-associated neurodegeneration"},{"lang":"en","label":"Seitelberger disease"}]}],"DisorderGeneAssociationList":[{"count":"1","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"phospholipase A2 group VI"}],"Symbol":"PLA2G6","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"9039"},{"Source":"OMIM","Reference":"603604"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"317343","Name":[{"lang":"en","label":"Disease-causing germline mutation(s) in"}]}]}]}],"HPODisorderAssociationList":[{"count":"8","HPODisorderAssociation":[{"HPOId":"HP:0000496","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000496","HPOTerm":"Abnormality of eye movement","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0000505","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000505","HPOTerm":"Visual impairment","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]},{"HPOId":"HP:0000639","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000639","HPOTerm":"Nystagmus","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0000648","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0000648","HPOTerm":"Optic atrophy","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0001250","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001250","HPOTerm":"Seizures","HPOFrequency":[{"ORPHA":"453313","Name":[{"lang":"en","label":"Occasional (29-5%)"}]}]},{"HPOId":"HP:0001252","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0001252","HPOTerm":"Muscular hypotonia","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0002376","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0002376","HPOTerm":"Developmental regression","HPOFrequency":[{"ORPHA":"453311","Name":[{"lang":"en","label":"Very frequent (99-80%)"}]}]},{"HPOId":"HP:0004326","PURL":"http:\/\/purl.obolibrary.org\/obo\/HP_0004326","HPOTerm":"Cachexia","HPOFrequency":[{"ORPHA":"453312","Name":[{"lang":"en","label":"Frequent (79-30%)"}]}]}]}],"HPODisorderSetStatus":[{"ValidationStatus":"y"}]}]}